In fact, the use of metformin has been hypothesized to contrast pediatric sarcomas such as osteosarcoma, Ewing sarcoma, and rhabdomyosarcoma, representing common pediatric sarcomas, that depend on insulin-like growth factor (IGF) and insulin for pathogenesis and progression. This evidence concerns the gene INS and sarcoma.